Active ulcerative colitis remission induction. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Colon Intestinal Mucosa Rectum Colonic Pouches Bone Marrow Colon, Sigmoid Ileum

Organisms1

Mice, Inbred C57BL

Diseases27

Colitis, Ulcerative Colitis Crohn Disease Inflammatory Bowel Diseases Remission, Spontaneous Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myeloid, Acute Colitis, Ischemic Pouchitis Recurrence Acute Disease Leukemia, Myeloid Leukemia, Lymphoid Colitis, Collagenous Neoplasm, Residual Leukemia, Promyelocytic, Acute Colitis, Microscopic Leukemia Blast Crisis Colitis, Lymphocytic Proctitis Cholangitis, Sclerosing Disseminated Intravascular Coagulation Megacolon, Toxic Ileitis Colonic Neoplasms Disease Models, Animal

Chemicals and Drugs31

Mesalamine Aminosalicylic Acids Gastrointestinal Agents Sulfasalazine Prednisolone Adjuvants, Pharmaceutic Cytarabine Anti-Inflammatory Agents Asparaginase Anti-Inflammatory Agents, Non-Steroidal Daunorubicin 6-Mercaptopurine Adrenal Cortex Hormones Methotrexate Vincristine Thioguanine Idarubicin Dextran Sulfate Prednisone Antibodies, Monoclonal Cyclophosphamide Trinitrobenzenesulfonic Acid Etoposide Doxorubicin Azathioprine Antineoplastic Agents Immunosuppressive Agents Dexamethasone RNA, Messenger Antibodies, Antineutrophil Cytoplasmic Peroxidase

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Remission Induction Enema Sigmoidoscopy Treatment Outcome Cytapheresis Leukapheresis Administration, Rectal Colonoscopy Double-Blind Method Administration, Oral Severity of Illness Index Proctocolectomy, Restorative Antineoplastic Combined Chemotherapy Protocols Colectomy Ileostomy Prognosis Disease-Free Survival Colonic Pouches Drug Administration Schedule Follow-Up Studies Drug Therapy, Combination Bone Marrow Transplantation Combined Modality Therapy Survival Analysis Leukocyte Count Clinical Trials as Topic Platelet Count Retrospective Studies Prospective Studies Biopsy Survival Rate Injections, Spinal Transplantation, Homologous Hematopoietic Stem Cell Transplantation Disease Models, Animal

Phenomena and Processes6

Remission, Spontaneous Enzyme Induction Dose-Response Relationship, Drug Time Factors Leukocyte Count Platelet Count

Information Science1

Health Care11

Treatment Outcome Double-Blind Method Severity of Illness Index Disease-Free Survival Follow-Up Studies Survival Analysis Clinical Trials as Topic Retrospective Studies Prospective Studies Survival Rate Age Factors

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Colitis, Ulcerative Mesalamine Remission Induction Aminosalicylic Acids Colitis Gastrointestinal Agents Crohn Disease Enema Colon Sulfasalazine Inflammatory Bowel Diseases Intestinal Mucosa Sigmoidoscopy Remission, Spontaneous Prednisolone Treatment Outcome Cytapheresis Adjuvants, Pharmaceutic Cytarabine Leukapheresis Administration, Rectal Anti-Inflammatory Agents Rectum Asparaginase Colonoscopy Anti-Inflammatory Agents, Non-Steroidal Double-Blind Method Daunorubicin Precursor Cell Lymphoblastic Leukemia-Lymphoma 6-Mercaptopurine Administration, Oral Leukemia, Myeloid, Acute Adrenal Cortex Hormones Methotrexate Vincristine Severity of Illness Index Proctocolectomy, Restorative Antineoplastic Combined Chemotherapy Protocols Thioguanine Colitis, Ischemic Idarubicin Dextran Sulfate Pouchitis Colectomy Prednisone Recurrence Acute Disease Antibodies, Monoclonal Leukemia, Myeloid Leukemia, Lymphoid Colitis, Collagenous Ileostomy Prognosis Enzyme Induction Dose-Response Relationship, Drug Cyclophosphamide Disease-Free Survival Trinitrobenzenesulfonic Acid Neoplasm, Residual Colonic Pouches Leukemia, Promyelocytic, Acute Time Factors Colitis, Microscopic Bone Marrow Leukemia Drug Administration Schedule Etoposide Doxorubicin Follow-Up Studies Drug Therapy, Combination Blast Crisis Bone Marrow Transplantation Azathioprine Combined Modality Therapy Survival Analysis Leukocyte Count Colitis, Lymphocytic Clinical Trials as Topic Antineoplastic Agents Proctitis Cholangitis, Sclerosing Platelet Count Disseminated Intravascular Coagulation Retrospective Studies Megacolon, Toxic Prospective Studies Colon, Sigmoid Ileitis Biopsy Survival Rate Ileum Injections, Spinal Immunosuppressive Agents Dexamethasone Transplantation, Homologous Hematopoietic Stem Cell Transplantation RNA, Messenger Colonic Neoplasms Antibodies, Antineutrophil Cytoplasmic Peroxidase

No FAQ available that match "active ulcerative colitis remission induction"